AAAAAA

   
Results: 1-7 |
Results: 7
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
Authors: Douillard, JY Cunningham, D Roth, AD Navarro, M James, RD Karasek, P Jandik, P Iveson, T Carmichael, J Alakl, M Gruia, G Awad, L Rougier, P
Citation: Jy. Douillard et al., Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial, LANCET, 355(9209), 2000, pp. 1041-1047
Phase I study of irinotecan and raltitrexed in patients with advanced gastrointestinal tract adenocarcinoma
Authors: Ford, HER Cunningham, D Ross, PJ Rao, S Aherne, GW Benepal, TS Price, T Massey, A Vernillet, L Gruia, G
Citation: Her. Ford et al., Phase I study of irinotecan and raltitrexed in patients with advanced gastrointestinal tract adenocarcinoma, BR J CANC, 83(2), 2000, pp. 146-152
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
Authors: Giacchetti, S Itzhaki, M Gruia, G Adam, R Zidani, R Kunstlinger, F Brienza, S Alafaci, E Bertheault-Cvitkovic, F Jasmin, C Reynes, M Bismuth, H Misset, JL Levi, F
Citation: S. Giacchetti et al., Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery, ANN ONCOL, 10(6), 1999, pp. 663-669
Dose-finding study of docetaxel and doxorubicin in first-line treatment ofpatients with metastatic breast cancer
Authors: Misset, JL Dieras, V Gruia, G Bourgeois, H Cvitkovic, E Kalla, S Bozec, L Beuzeboc, P Jasmin, C Aussel, JP Riva, A Azli, N Pouillart, P
Citation: Jl. Misset et al., Dose-finding study of docetaxel and doxorubicin in first-line treatment ofpatients with metastatic breast cancer, ANN ONCOL, 10(5), 1999, pp. 553-560
Phase I and pharmacokinetic study of irinotecan administered as a low-dose, continuous intravenous infusion over 14 days in patients with malignant solid tumors
Authors: Herben, VMM Schellens, JHM Swart, M Gruia, G Vernillet, L Beijnen, JH Huinink, WWT
Citation: Vmm. Herben et al., Phase I and pharmacokinetic study of irinotecan administered as a low-dose, continuous intravenous infusion over 14 days in patients with malignant solid tumors, J CL ONCOL, 17(6), 1999, pp. 1897-1905
Treatment with a nonanthracycline regimen in advanced breast cancer - Vinorelbine, cyclophosphamide, and 5-fluorouracil with folinic acid
Authors: Turpin, F Lluch, A Closen, MH Gruia, G Llombart, A Fernandez, R Delgado, FM Biville, F
Citation: F. Turpin et al., Treatment with a nonanthracycline regimen in advanced breast cancer - Vinorelbine, cyclophosphamide, and 5-fluorouracil with folinic acid, AM J CL ONC, 22(2), 1999, pp. 196-198
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
Authors: Van Cutsem, E Pozzo, C Starkhammar, H Dirix, L Terzoli, E Cognetti, E Humblet, Y Garufi, C Filez, L Gruia, G Cote, C Barone, C
Citation: E. Van Cutsem et al., A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer, ANN ONCOL, 9(11), 1998, pp. 1199-1204
Risultati: 1-7 |